BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31703373)

  • 1. Design, Synthesis and Preliminary Biological Evaluation of Benzylsulfone Coumarin Derivatives as Anti-Cancer Agents.
    Wang T; Peng T; Wen X; Wang G; Sun Y; Liu S; Zhang S; Wang L
    Molecules; 2019 Nov; 24(22):. PubMed ID: 31703373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Structure-Activity Relationships of 4-Morpholino-7,8-Dihydro-5H-Thiopyrano[4,3-d]pyrimidine Derivatives Bearing Pyrazoline Scaffold.
    Wang Q; Li X; Sun C; Zhang B; Zheng P; Zhu W; Xu S
    Molecules; 2017 Oct; 22(11):. PubMed ID: 29088090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eco-friendly synthesis of novel cyanopyridine derivatives and their anticancer and PIM-1 kinase inhibitory activities.
    Abouzid KAM; Al-Ansary GH; El-Naggar AM
    Eur J Med Chem; 2017 Jul; 134():357-365. PubMed ID: 28431341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors.
    Ma CC; Liu ZP
    Anticancer Agents Med Chem; 2017; 17(3):395-403. PubMed ID: 26902599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, molecular docking and in silico ADMET profile of pyrano[2,3-d]pyrimidine derivatives as antimicrobial and anticancer agents.
    Abd El-Sattar NEA; El-Adl K; El-Hashash MA; Salama SA; Elhady MM
    Bioorg Chem; 2021 Oct; 115():105186. PubMed ID: 34314914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of new coumarin derivatives as cytotoxic agents.
    Ragab FA; Eissa AAM; Fahim SH; Salem MA; Gamal MA; Nissan YM
    Arch Pharm (Weinheim); 2021 Aug; 354(8):e2100029. PubMed ID: 33872414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis.
    Mohamed TK; Batran RZ; Elseginy SA; Ali MM; Mahmoud AE
    Bioorg Chem; 2019 Apr; 85():253-273. PubMed ID: 30641320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, antitumor activity evaluation, and DNA-binding study of coumarin-based agents.
    Amin KM; Taha AM; George RF; Mohamed NM; Elsenduny FF
    Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29148081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, in silico and in vitro evaluation of thiophene derivatives: A potent tyrosine phosphatase 1B inhibitor and anticancer activity.
    Gulipalli KC; Bodige S; Ravula P; Endoori S; Vanaja GR; Suresh Babu G; Narendra Sharath Chandra JN; Seelam N
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3558-3564. PubMed ID: 28579122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of novel diazaphosphinanes coumarin derivatives with promoted cytotoxic and anti-tyrosinase activities.
    Gardelly M; Trimech B; Belkacem MA; Harbach M; Abdelwahed S; Mosbah A; Bouajila J; Ben Jannet H
    Bioorg Med Chem Lett; 2016 May; 26(10):2450-2454. PubMed ID: 27080182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of novel 3-substituted 4-anilino-coumarin derivatives as antitumor agents.
    Luo G; Muyaba M; Lyu W; Tang Z; Zhao R; Xu Q; You Q; Xiang H
    Bioorg Med Chem Lett; 2017 Feb; 27(4):867-874. PubMed ID: 28110871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Biological Activity Evaluation of Coumarin-3-Carboxamide Derivatives.
    Phutdhawong W; Chuenchid A; Taechowisan T; Sirirak J; Phutdhawong WS
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33809679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining properties of different classes of PI3Kα inhibitors to understand the molecular features that confer selectivity.
    Gong GQ; Kendall JD; Dickson JMJ; Rewcastle GW; Buchanan CM; Denny WA; Shepherd PR; Flanagan JU
    Biochem J; 2017 Jun; 474(13):2261-2276. PubMed ID: 28526744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, Synthesis and Biological Evaluation of Novel Benzothiazole Derivatives as Selective PI3Kβ Inhibitors.
    Cao S; Cao R; Liu X; Luo X; Zhong W
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27384552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anticancer evaluation of novel 1H-benzo[d]imidazole derivatives of dehydroabietic acid as PI3Kα inhibitors.
    Yang YQ; Chen H; Liu QS; Sun Y; Gu W
    Bioorg Chem; 2020 Jul; 100():103845. PubMed ID: 32344183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of novel series of 2H-benzo[b][1,4]oxazin-3(4H)-one and 2H-benzo[b][1,4]oxazine scaffold derivatives as PI3Kα inhibitors.
    Dong FD; Liu DD; Deng CL; Qin XC; Chen K; Wang J; Song HR; Ding HW
    Bioorg Med Chem; 2018 Aug; 26(14):3982-3991. PubMed ID: 29937355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Based Design: Synthesis, X-ray Crystallography, and Biological Evaluation of N-Substituted-4-Hydroxy-2-Quinolone-3-Carboxamides as Potential Cytotoxic Agents.
    Sabbah DA; Hishmah B; Sweidan K; Bardaweel S; AlDamen M; Zhong HA; Abu Khalaf R; Hasan Ibrahim A; Al-Qirim T; Abu Sheikha G; Mubarak MS
    Anticancer Agents Med Chem; 2018; 18(2):263-276. PubMed ID: 28901259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling the Alkaline Phosphatase Inhibition, Anticancer, and Antileishmanial Potential of Coumarin-Triazolothiadiazine Hybrids: Design, Synthesis, and Molecular Docking Analysis.
    Ibrar A; Zaib S; Jabeen F; Iqbal J; Saeed A
    Arch Pharm (Weinheim); 2016 Jul; 349(7):553-65. PubMed ID: 27214743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis, and Biological Evaluation of Novel Thienopyrimidine Derivatives as PI3Kα Inhibitors.
    Yu L; Wang Q; Wang C; Zhang B; Yang Z; Fang Y; Zhu W; Zheng P
    Molecules; 2019 Sep; 24(19):. PubMed ID: 31547116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.